This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
pathway Info Card
Error-prone Translesion Synthesis
Information about Error-prone Translesion Synthesis: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Error-prone Translesion Synthesis
Most recent studies have shown that Error-prone Translesion Synthesis shares some biological mechanisms with cell-cycle, cell-death, dna-repair, dna-replication, drug-resistance, gastrulation, gene-conversion, immune-response, innate-immune-response, post-translational-protein-modification, protein-ubiquitination, s-phase, translesion-synthesis.
Among the many pathways, these few ones have gauged particular interests from scientists studying Error-prone Translesion Synthesis, and have been seen in publications frequently: cell-cycle, cell-death, dna-repair, dna-replication, drug-resistance, gastrulation, gene-conversion, immune-response, innate-immune-response, post-translational-protein-modification, protein-ubiquitination, s-phase, translesion-synthesis
Quite a number of genes have been found to play important roles in Error-prone Translesion Synthesis, such as ATAD5, FANCG, FUS, HPRT1, MAD2L2, PAH, PCNA, POLB, POLH, POLQ, Pol, Polk, REV1, REV3L, RFC1, SLC19A1, UBE2V2, UNG, USP1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this pathway. Plesae stay updated.